Enhancing Profitable Growth in MedTech
Driving top line measures in an increasingly challenging market environment
Many Medtech companies struggle to deliver the desired growth and simultaneously meet profitability expectations due to a number of challenging market dynamics. Customer consolidation and procurement centralization/ professionalization are putting pressure on prices. A continuing high need for customer intimacy and service expectations are driving up cost-to-serve. At the same time, the profit pressure relief provided by launching new products is digressive, as constrained budgets limit the room for access at premium prices and make the monetization of innovations challenging.
While still growing and benefiting from favorable demographics, many MedTech companies are facing increasing margin pressure. Typically companies tend to focus on inward looking cost cutting as a counter measure to improve profitability. However, best-in-class MedTech companies go beyond and look for ways to enhance profitability with effective top line measures in the context of maximizing portfolio monetization, optimizing deal profitability and enhancing sales effectiveness.
Join us for the Simon-Kucher & Partners 2nd MedTech Webinar Series, where our experts will share insights, practical approaches and best practice examples on unleashing incremental profits through best-in-class top line management.